Cambridge Investment Research Advisors’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Buy
259,625
+13,816
+6% +$618K 0.02% 627
2026
Q1
$9.94M Buy
245,809
+33,188
+16% +$1.47M 0.03% 622
2025
Q4
$9.77M Buy
212,621
+18,828
+10% +$859K 0.03% 592
2025
Q3
$8.87M Sell
193,793
-13,042
-6% -$578K 0.02% 623
2025
Q2
$8.52M Sell
206,835
-6,047
-3% -$224K 0.03% 603
2025
Q1
$7.43M Buy
212,882
+4,370
+2% +$165K 0.03% 616
2024
Q4
$7.99M Sell
208,512
-440
-0.2% -$16.6K 0.03% 577
2024
Q3
$7.41M Buy
208,952
+18,444
+10% +$582K 0.03% 614
2024
Q2
$5.28M Buy
190,508
+6,771
+4% +$189K 0.02% 728
2024
Q1
$5.13M Buy
183,737
+5,123
+3% +$138K 0.02% 727
2023
Q4
$4.78M Buy
178,614
+9,420
+6% +$214K 0.02% 727
2023
Q3
$3.53M Buy
169,194
+21,721
+15% +$489K 0.02% 838
2023
Q2
$3.31M Buy
147,473
+4,574
+3% +$96.9K 0.02% 873
2023
Q1
$3.1M Buy
142,899
+15,333
+12% +$345K 0.02% 884
2022
Q4
$2.67M Sell
127,566
-19,417
-13% -$435K 0.01% 920
2022
Q3
$3.24M Buy
146,983
+14,795
+11% +$383K 0.02% 779
2022
Q2
$3.17M Sell
132,188
-9,223
-7% -$246K 0.02% 816
2022
Q1
$4.31M Sell
141,411
-20,147
-12% -$602K 0.02% 702
2021
Q4
$5.26M Buy
161,558
+17,900
+12% +$566K 0.02% 621
2021
Q3
$4.14M Buy
143,658
+4,347
+3% +$127K 0.02% 692
2021
Q2
$3.83M Buy
139,311
+3,322
+2% +$85.1K 0.02% 752
2021
Q1
$3.24M Buy
135,989
+35,190
+35% +$785K 0.02% 764
2020
Q4
$2.23M Buy
100,799
+1,920
+2% +$38.4K 0.01% 874
2020
Q3
$1.75M Buy
98,879
+9,980
+11% +$178K 0.01% 871
2020
Q2
$1.56M Buy
88,899
+25,577
+40% +$450K 0.01% 885
2020
Q1
$1M Sell
63,322
-104,455
-62% -$2.15M 0.01% 970
2019
Q4
$3.46M Buy
167,777
+40,127
+31% +$800K 0.03% 596
2019
Q3
$2.42M Buy
127,650
+78,454
+159% +$1.42M 0.02% 672
2019
Q2
$839K Buy
49,196
+10,757
+28% +$182K 0.01% 1122
2019
Q1
$640K Buy
38,439
+4,240
+12% +$66K 0.01% 1319
2018
Q4
$468K Sell
34,199
-6,516
-16% -$97.2K 0.01% 1361
2018
Q3
$647K Buy
40,715
+168
+0.4% +$2.55K 0.01% 1295
2018
Q2
$586K Buy
40,547
+6,480
+19% +$92.5K 0.01% 1317
2018
Q1
$474K Buy
34,067
+1,219
+4% +$17.6K 0.01% 1381
2017
Q4
$510K Sell
32,848
-4,325
-12% -$65.3K 0.01% 1312
2017
Q3
$548K Buy
37,173
+2,038
+6% +$28.6K 0.01% 1212
2017
Q2
$492K Buy
35,135
+1,502
+4% +$20.2K 0.01% 1213
2017
Q1
$438K Buy
33,633
+1,261
+4% +$16K 0.01% 1141
2016
Q4
$381K Buy
32,372
+1,895
+6% +$23.1K 0.01% 1143
2016
Q3
$383K Sell
30,477
-5,367
-15% -$65.7K 0.01% 1171
2016
Q2
$423K Buy
35,844
+5,116
+17% +$61.2K 0.01% 1012
2016
Q1
$375K Sell
30,728
-19,062
-38% -$205K 0.01% 1053
2015
Q4
$551K Sell
49,790
-1,612
-3% -$18.9K 0.01% 815
2015
Q3
$568K Buy
51,402
+15,318
+42% +$179K 0.02% 698
2015
Q2
$443K Buy
36,084
+8,914
+33% +$113K 0.01% 870
2015
Q1
$341K Buy
+27,170
New +$337K 0.01% 994

Other funds holding BN

Cambridge Investment Research Advisors's BN Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Brookfield (BN) stake by 5.6% in Q2 2026, buying an estimated $618K and bringing the position to 259,625 shares worth $11.1M. The position accounts for 0.02% of the portfolio, ranked #627.

Cambridge Investment Research Advisors first reported a position in BN in Q1 2015 and has held it in 46 quarters since. 940 funds tracked by Wall St. Rank hold BN as of Q2 2026.

  • Cambridge Investment Research Advisors held 259,625 shares of Brookfield worth $11.1M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 13,816 Brookfield shares in Q2 2026, an estimated $618K.
  • Brookfield made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #627 holding.
  • Cambridge Investment Research Advisors first reported a position in Brookfield in Q1 2015 and has held it in 46 quarters since.
  • 940 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.